AgoneX Biopharmaceuticals Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous AGX-201 for Migraine Prophylaxis
Phase 2
- Conditions
- Migraine Prophylaxis
- Interventions
- Drug: Subcutaneous placebo (Evan's solution = phenol 0.4%, isotonic sodium chloride).
- First Posted Date
- 2013-12-27
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- AgoneX Biopharmaceuticals, Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT02021474
News
No news found